Stock Information
Cytokinetics Inc (CYTK)
Ticker Symbol: CYTK
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $7,857,885,434.00 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -6.3098
Revenue (TTM): $0.73 M
Dividend Yield: N/A%
ROE: -131.19%
Latest News
-
Cytokinetics: Small Label Differences With Big Commercial Stakes
Mon, Dec 22, 2025 5:33 PM
-
Cytokinetics Wins FDA Approval for Cardiovascular Drug, Stock up
Mon, Dec 22, 2025 2:29 PM
-
Cytokinetics, Incorporated (CYTK) Discusses FDA Approval of MYQORZO for Symptomatic Obstructive Hypertrophic Cardiomyopathy Transcript
Mon, Dec 22, 2025 9:47 AM
Key Financials
Financial data not available
